Medicare Enrolled
Dr. Maged Amine, MD
Cardiovascular Disease · Houston, TX
Practice pattern: Cardiac Imaging
— Practice with significant diagnostic imaging and stress testing
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Amine from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Amine?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Amine
Dr. Maged Amine is a cardiovascular disease specialist in Houston, TX, with 21 years of NPI registration. Based on federal Medicare data, Dr. Amine performed 4,391 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Amine received a total of $40,747 from 54 pharmaceutical and/or device companies across 668 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Amine is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years of NPI registration
▲ Top 23% volume in TX
$40,747 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗4,391
Medicare services
Top 23% in TX for cardiovascular disease
Not available
Unique patients (not deduplicated)
$87
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
863 | $91 | $314 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
680 | $6 | $50 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
456 | $43 | $212 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
443 | $10 | $126 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
360 | $118 | $1,262 |
| Technetium Tc-99m tetrofosmin diagnostic injection A diagnostic injection of Technetium Tc-99m tetrofosmin used for imaging studies. |
268 | $25 | $35 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
169 | $50 | $406 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
166 | $323 | $3,267 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
142 | $118 | $483 |
| Remote cardiac rhythm monitor evaluation, up to 30 days Review and analysis of data from a remote cardiac rhythm monitoring system over a period of up to 30 days. |
96 | $21 | $120 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
73 | $22 | $149 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers. |
67 | $144 | $1,028 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
62 | $102 | $401 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
56 | $10 | $64 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
42 | $147 | $1,003 |
| Cardiac catheterization | 40 | $189 | $1,310 |
| Continuous ECG monitoring with transmission and review Continuous electrocardiogram monitoring for up to 30 days with symptom tracking. The data is transmitted and reviewed by a healthcare professional who provides a report. |
39 | $16 | $111 |
| Chemical destruction of first incompetent vein with imaging guidance This procedure uses imaging guidance to chemically destroy the first incompetent vein in the arm or leg. |
37 | $1,450 | $11,970 |
| Remote monitoring of implantable heart device, up to 30 days Remote evaluation of an implanted heart or blood vessel monitoring system over a period of up to 30 days. |
37 | $20 | $104 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
37 | $40 | $263 |
| Pacemaker system evaluation Assessment of a pacemaker device, including single, dual, multiple lead, or leadless systems. |
36 | $41 | $175 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
35 | $59 | $212 |
| Ultrasound of arm and leg arteries This procedure uses sound waves to create images of the blood vessels in the arms and legs. It allows healthcare providers to examine the structure and blood flow within these arteries. |
23 | $55 | $484 |
| Continuous external EKG monitoring, 48 hours to 7 days This procedure involves recording the heart's electrical activity continuously using an external device for a period exceeding 48 hours but not more than 7 days. |
20 | $10 | $63 |
| Continuous EKG monitoring review, 48-7 days Review and interpretation of continuous external EKG recordings lasting more than 48 hours up to 7 days. |
20 | $19 | $102 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in one arm or leg using compression and other maneuvers to assess blood flow and check for blockages. |
19 | $97 | $680 |
| Coronary stent placement A procedure to insert a stent into a coronary artery or its branch to keep it open, using balloon dilation during the process. |
18 | $461 | $2,405 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
17 | $10 | $66 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
17 | $96 | $302 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
16 | $2 | $252 |
| Cardiac rhythm monitor evaluation Review and analysis of data recorded by a cardiac rhythm monitoring device to assess heart activity. |
15 | $36 | $168 |
| Insertion of implantable heart rhythm monitor A small device is placed under the skin to continuously record the heart's electrical activity. This helps detect irregular heart rhythms that may not appear during a standard office visit. |
11 | $3,523 | $26,634 |
| Transesophageal echocardiogram An ultrasound of the heart performed using a probe inserted into the esophagus to obtain detailed images of heart structures and function. |
11 | $85 | $472 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
12.0% high complexity
30.2% medium
57.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$40,747
Total received (2018-2024)
Avg $5,821/year across 7 years
Top 12% in TX for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
54
Companies
668
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,674
2023
$5,463
2022
$4,418
2021
$1,824
2020
$879
2019
$6,533
2018
$16,955
Payments by company (2024)
Abbott Laboratories
$1,245
ABIOMED
$869
Novartis Pharmaceuticals Corporation
$431
Medtronic, Inc.
$288
Impulse Dynamics (USA) Inc.
$206
Lexicon Pharmaceuticals, Inc.
$199
Boston Scientific Corporation
$179
HEARTFLOW, INC.
$164
Tactile Systems Technology Inc
$105
PFIZER INC.
$104
Biosense Webster, Inc.
$99
Baxter Healthcare
$92
Boehringer Ingelheim Pharmaceuticals, Inc.
$89
Merck Sharp & Dohme LLC
$86
AngioDynamics, Inc.
$79
Novo Nordisk Inc
$76
iRhythm Technologies, Inc.
$68
Amgen Inc.
$64
Actelion Pharmaceuticals US, Inc.
$60
E.R. Squibb & Sons, L.L.C.
$55
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$52
Azurity Pharmaceuticals, Inc.
$19
Kiniksa Pharmaceuticals International, plc
$16
GE HEALTHCARE
$14
Cook Medical LLC
$14
Top 3 companies account for 54.5% of 2024 payments
All-time payments by company (2018-2024) ›
Abbott Laboratories
$8,744
Medtronic Vascular, Inc.
$7,508
Novartis Pharmaceuticals Corporation
$6,284
Chiesi USA, Inc.
$4,381
ABIOMED
$1,873
Impulse Dynamics (USA) Inc.
$1,502
ARALEZ PHARMACEUTICALS US INC.
$1,125
Boston Scientific Corporation
$865
Biosense Webster, Inc.
$862
Amgen Inc.
$826
Bard Peripheral Vascular, Inc.
$479
Janssen Pharmaceuticals, Inc
$463
BARD PERIPHERAL VASCULAR, INC.
$430
Actelion Pharmaceuticals US, Inc.
$354
Medtronic, Inc.
$344
PFIZER INC.
$340
Boehringer Ingelheim Pharmaceuticals, Inc.
$306
Medtronic USA, Inc.
$279
Amarin Pharma Inc.
$277
HeartFlow, Inc.
$264
Baxter Healthcare
$248
Merck Sharp & Dohme LLC
$248
Esperion Therapeutics, Inc.
$237
Tactile Systems Technology Inc
$230
Lexicon Pharmaceuticals, Inc.
$219
E.R. Squibb & Sons, L.L.C.
$209
SANOFI-AVENTIS U.S. LLC
$207
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$169
HEARTFLOW, INC.
$164
AstraZeneca Pharmaceuticals LP
$159
BIOTRONIK INC.
$157
AngioDynamics, Inc.
$113
iRhythm Technologies, Inc.
$102
ARBOR PHARMACEUTICALS, INC.
$98
CARDIVA MEDICAL, INC.
$92
Novo Nordisk Inc
$90
Merck Sharp & Dohme Corporation
$67
Astellas Pharma US Inc
$64
Kiniksa Pharmaceuticals, Ltd.
$59
BOSTON SCIENTIFIC CORPORATION
$40
Gilead Sciences, Inc.
$38
Relypsa, Inc.
$31
Aziyo Biologics, Inc.
$29
Kowa Pharmaceuticals America, Inc.
$26
Inspire Medical Systems, Inc.
$25
Azurity Pharmaceuticals, Inc.
$19
Kiniksa Pharmaceuticals International, plc
$16
GE HEALTHCARE
$14
Cook Medical LLC
$14
Dilon Technologies, Inc.
$13
Regeneron Healthcare Solutions, Inc.
$12
AltaThera Pharmaceuticals LLC
$11
Itamar Medical Inc
$10
Bardy Diagnostics, Inc.
$10
Top 3 companies account for 55.3% of all-time payments
Associated products mentioned in payments ›
AMVIA EDGE · AQUAMANTYS · ASSURITY · AURYON LASER SYSTEM 100-120 VAC · AVEIR · Arcalyst · Assurity Pacemaker · BIOMONITOR · BRILINTA · BodyGuardian · CAMZYOS · CARDENE · CARDIOMEMS · CARDIVA VASCADE MVP VVCS 6-12F · CARTO 3 · COBALT DR MRI SURESCAN · CONFIRM RX · CROSSER · CardioMEMS HF System · Carnation Ambulatory Monitor · Carto 3 System · Carto Smarttouch · Claria MRI · ClosureRFS · Confirm Rx · Connectivity and Remote care · CoreValve Evolut · Corlanor · DxTerity · ECM · EDARBI · ELIQUIS · ENSITE · ENSITE PRECISION · ENTRESTO · Edarbi · Edarbyclor · Ellipse ICD · FARXIGA · FFRct · FLEXITOUCH · Flexitouch Plus · Fortify Assura · GALLANT · General - Therapies · HeartMate · HeartMate 3 Left Ventricular Assist Device · HeartWare HVAD · Hillrom - Cardiac Ambulatory Monitor · Hillrom - Carnation Ambulatory Monitor · INSPIRE · Impella · Inpefa · JARDIANCE · JOT DX · KENGREAL · LATITUDE Communicator Power Supply · LEQVIO · LEXISCAN · LIFESTENT · LINQ II · LUTONIX · LUX DX · LUX-Dx Insertable Cardiac Monitor · LifeVest · Livalo · MERLIN@HOME · MICRA · MITRACLIP · MULTAQ · Merlin Connectivity and Remote · Miami Instruments Joseph Lamelas Knot Pusher · Mitra Clip system · MyCareLink Smart · NEXLETOL · NEXLIZET · OPSUMIT · OPTIMIZER · OPTIS · Optimizer · Ozempic · PRALUENT · PRESSUREWIRE · Percepta · PlasmaBlade · Quadra Allure MP RF CRT Pacemkr · Quartet CRT Lead · RESONATE EL ICD VR · Repatha · Resolute · Reveal LINQ · Rivacor 7 DR-T · SELECTSITE · Sotalol Hydrochloride · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · TRUEVIEW · ULTRASCORE · UPTRAVI · VASCUTRAK · VENOVO · VERQUVO · VYNDAQEL · Vascepa · Veltassa · VenaSeal · Venclose Maven Catheter · Visia AF · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · WatchPAT · XARELTO · XIENCE V · ZILVER PTX · ZIO XT Patch · ZONTIVITY
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Cardiologists in nearby ZIP areas
382
County median income
$73,104
Nearest hospital to ZIP centroid (approximate)
HOUSTON METHODIST WILLOWBROOK HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Amine is a cardiac imaging specialist, with above-average Medicare volume (top 23% in TX), with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Amine experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Amine performed 863 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Amine receive payments from pharmaceutical companies?
Yes. Dr. Amine received a total of $40,747 from 54 companies across 668 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Amine's costs compare to other cardiologists in Houston?
Dr. Amine's average Medicare payment per service is $87. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Amine) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Houston
Browse cardiologists in Houston ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in TX
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in TX
Which TX cardiologists receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Medtronic Vascular, Inc. Payments to Doctors
See all physicians who received payments from Medtronic Vascular, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology